We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B Turnover 17.35%
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+23.15%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$441M
AUM Growth
+$79.3M
Cap. Flow
-$4.47M
Cap. Flow %
-1.01%
Top 10 Hldgs %
71.35%
Holding
76
New
11
Increased
22
Reduced
17
Closed
4
Avg Time Held
0.9 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.16%
2 Healthcare 2.46%
3 Real Estate 0.43%
4 Consumer Staples 0.33%
5 Technology 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DSI icon
51
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$591K 0.13%
15,432
– –
2013 Q2
6 quarters
ARE icon
52
Alexandria Real Estate Equities
ARE
$7.29B
$578K 0.13%
6,509
– –
2014 Q2
2 quarters
AAPL icon
53
Apple
AAPL
$4.99T
$534K 0.12%
19,344
-3,484
-15% -$94.8K
2014 Q2
2 quarters
MBFI
54
DELISTED
MB Financial Corp
MBFI
$516K 0.12%
15,705
– –
2014 Q2
2 quarters
CUDA
55
DELISTED
Barracuda Networks, Inc.
CUDA
$493K 0.11%
13,750
– –
2014 Q3
1 quarter
KND
56
DELISTED
Kindred Healthcare
KND
$481K 0.11%
26,468
– –
2014 Q3
1 quarter
SPY icon
57
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$403K 0.09%
1,960
+919
+88% +$185K
2014 Q3
1 quarter
IPCM
58
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$381K 0.09%
8,293
– –
2014 Q2
2 quarters
VDE icon
59
Vanguard Energy ETF
VDE
$11.2B
$327K 0.07%
+2,930
New +$349K
2014 Q4
0 quarters
ACAD icon
60
Acadia Pharmaceuticals
ACAD
$3.4B
$318K 0.07%
10,000
– –
2014 Q3
1 quarter
TSLA icon
61
Tesla
TSLA
$1.43T
$299K 0.07%
20,145
-30
-0.1% -$469
2014 Q2
2 quarters
ILMN icon
62
Illumina
ILMN
$40.5B
$294K 0.07%
1,637
– –
2014 Q1
3 quarters
IMUC
63
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$288K 0.07%
9,848
– –
2013 Q2
6 quarters
DLN icon
64
WisdomTree US LargeCap Dividend Fund
DLN
$6.31B
$279K 0.06%
7,520
– –
2013 Q2
6 quarters
GILD icon
65
Gilead Sciences
GILD
$195B
$278K 0.06%
+2,948
New +$305K
2014 Q4
0 quarters
EFA icon
66
iShares MSCI EAFE ETF
EFA
$76.9B
$223K 0.05%
+3,665
New +$229K
2014 Q4
0 quarters
IVV icon
67
iShares Core S&P 500 ETF
IVV
$889B
$211K 0.05%
1,020
– –
2014 Q3
1 quarter
SRE icon
68
Sempra
SRE
$53.6B
$206K 0.05%
+3,696
New +$201K
2014 Q4
0 quarters
ASRT icon
69
DELISTED
Assertio
ASRT
$161K 0.04%
167
– –
2014 Q2
2 quarters
SEEL icon
70
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
2014 Q2
2 quarters
DBC icon
71
Invesco DB Commodity Index Tracking Fund
DBC
$1.97B
– –
-57,072
Closed -$1.32M –
MINT icon
72
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.6B
– –
-9,380
Closed -$951K –
CSOD
73
DELISTED
Cornerstone OnDemand, Inc.
CSOD
– –
-15,000
Closed -$516K –
TLRA
74
DELISTED
Telaria, Inc.
TLRA
– –
-42,828
Closed -$100K –

Similar funds

Callan Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Callan Capital held 76 positions worth $441M, up 22% from $361M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Callan Capital's Q4 2014 filing shows 11 new, 22 increased, 17 reduced and 4 closed positions. Its largest new stake was First Trust Global Tactical Commodity Strategy Fund: 526,461 shares worth $13.8M. The largest sale was RECEPTOS INC COM STK (DE), an estimated $28.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 96% a quarter earlier, followed by Healthcare and Real Estate.

  • Callan Capital's largest Q4 2014 buy was First Trust Global Tactical Commodity Strategy Fund: 526,461 shares worth $13.8M.
  • Callan Capital added most to iShares Europe ETF in Q4 2014, an estimated $3M increase.
  • Callan Capital's biggest Q4 2014 reduction was RECEPTOS INC COM STK (DE), cutting an estimated $28.4M.
  • Callan Capital fully exited Invesco DB Commodity Index Tracking Fund in Q4 2014, selling an estimated $1.32M.
  • Callan Capital's ten largest holdings make up 71% of its $441M portfolio in Q4 2014.
  • Callan Capital opened 11 new positions and closed 4 in Q4 2014.
  • Callan Capital's portfolio value rose 22% quarter-over-quarter to $441M.

Based on Callan Capital's 13F filing for Q4 2014, filed 10 Feb 2015.